{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:46:30Z","timestamp":1790343990433,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["BJ-2023-162"],"award-info":[{"award-number":["BJ-2023-162"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"DOI":"10.1186\/s12877-025-05960-3","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T07:39:29Z","timestamp":1745912369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inappropriate dosing of direct oral anticoagulants among very older inpatients with atrial fibrillation"],"prefix":"10.1186","volume":"25","author":[{"given":"Ya-Tong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Nan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Qiu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fan","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hao","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiefu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"12","key":"5960_CR1","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857\u201367.","journal-title":"ANN INTERN MED"},{"issue":"12","key":"5960_CR2","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, et al. Dabigatran versus warfarin in patients with atrial fibrillation. New Engl J Med. 2009;361(12):1139\u201351.","journal-title":"NEW ENGL J MED"},{"issue":"10","key":"5960_CR3","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. New Engl J Med. 2011;365(10):883\u201391.","journal-title":"NEW ENGL J MED"},{"issue":"22","key":"5960_CR4","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Spinar J, et al. Edoxaban versus warfarin in patients with atrial fibrillation. New Engl J Med. 2013;369(22):2093\u2013104.","journal-title":"NEW ENGL J MED"},{"issue":"24","key":"5960_CR5","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1016\/j.jacc.2016.09.966","volume":"68","author":"BA Steinberg","year":"2016","unstructured":"Steinberg BA, Shrader P, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel J, et al. Off-Label dosing of Non-Vitamin K antagonist oral anticoagulants and adverse outcomes: the ORBIT-AF II registry. J AM Coll Cardiol. 2016;68(24):2597\u2013604.","journal-title":"J AM COLL CARDIOL"},{"issue":"12","key":"5960_CR6","doi-asserted-by":"publisher","first-page":"e7971","DOI":"10.1161\/CIRCOUTCOMES.121.007971","volume":"14","author":"XL Zhang","year":"2021","unstructured":"Zhang XL, Zhang XW, Wang TY, Wang HW, Chen Z, Xu B, Xu W. Off-Label Under- and overdosing of direct oral anticoagulants in patients with atrial fibrillation: A Meta-Analysis. Circ Cardiovasc Qual Outcomes. 2021;14(12):e7971.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"8","key":"5960_CR7","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1111\/jgs.14855","volume":"65","author":"M Biteker","year":"2017","unstructured":"Biteker M, Basaran O, Dogan V, Altun I, Ozpamuk KF, Tekkesin AI, Cakilli Y, Turkkan C, Hamidi M, Demir V, et al. Real-World clinical characteristics and treatment patterns of individuals aged 80 and older with nonvalvular atrial fibrillation: results from the ReAl-life multicenter survey evaluating stroke study. J AM Geriatr Soc. 2017;65(8):1684\u201390.","journal-title":"J AM GERIATR SOC"},{"issue":"18","key":"5960_CR8","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.jacc.2018.03.019","volume":"71","author":"AB Curtis","year":"2018","unstructured":"Curtis AB, Karki R, Hattoum A, Sharma UC. Arrhythmias in patients >\/=80 years of age: pathophysiology, management, and outcomes. J AM Coll Cardiol. 2018;71(18):2041\u201357.","journal-title":"J AM COLL CARDIOL"},{"issue":"1","key":"5960_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","volume":"8","author":"S Schulman","year":"2010","unstructured":"Schulman S, Angeras U, Bergqvist D, Eriksson B, Lassen MR, Fisher W. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost. 2010;8(1):202\u20134.","journal-title":"J THROMB HAEMOST"},{"issue":"1","key":"5960_CR10","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/S2468-2667(19)30226-9","volume":"5","author":"A Dugravot","year":"2020","unstructured":"Dugravot A, Fayosse A, Dumurgier J, Bouillon K, Rayana TB, Schnitzler A, Kivimaki M, Sabia S, Singh-Manoux A. Social inequalities in Multimorbidity, frailty, disability, and transitions to mortality: a 24-year follow-up of the Whitehall II cohort study. Lancet Public Health. 2020;5(1):e42\u201350.","journal-title":"LANCET PUBLIC HEALTH"},{"issue":"1","key":"5960_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230.","journal-title":"BMC GERIATR"},{"key":"5960_CR12","doi-asserted-by":"crossref","unstructured":"Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N et al. 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. Europace. 2021;23(10):1612\u20131676.","DOI":"10.1093\/europace\/euab065"},{"issue":"5","key":"5960_CR13","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00228-022-03286-2","volume":"78","author":"A Carbone","year":"2022","unstructured":"Carbone A, Santelli F, Bottino R, Attena E, Mazzone C, Parisi V, D\u2019Andrea A, Golino P, Nigro G, Russo V. Prevalence and clinical predictors of inappropriate direct oral anticoagulant dosage in octagenarians with atrial fibrillation. Eur J Clin Pharmacol. 2022;78(5):879\u201386.","journal-title":"EUR J CLIN PHARMACOL"},{"issue":"4","key":"5960_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s40801-021-00263-6","volume":"8","author":"M Hupfer","year":"2021","unstructured":"Hupfer M, Gosch M. Anticoagulation in very old patients with atrial fibrillation (AVOPA): A descriptive observational study. Drugs-Real Wor Outc. 2021;8(4):603\u201314.","journal-title":"DRUGS-REAL WOR OUTC"},{"issue":"10","key":"5960_CR15","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s40266-021-00883-1","volume":"38","author":"DM Cavillon","year":"2021","unstructured":"Cavillon DM, Ferret L, Decaestecker K, Gautier S, Verdun S, Tsogli ES. Direct oral anticoagulants and Non-valvular atrial fibrillation: compliance with dose level guidelines in patients aged 80 years and over. Drug Aging. 2021;38(10):939\u201350.","journal-title":"DRUG AGING"},{"issue":"5","key":"5960_CR16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s41999-020-00343-w","volume":"11","author":"J de Almeida","year":"2020","unstructured":"de Almeida J, Martinho AS, Girao A, Barreiro I, Milner J, Ferreira M, Carvalho A, Baptista RT, Goncalves L. Novel anticoagulants in an older and frail population with atrial fibrillation: the effect of inappropriate dosing on clinical outcomes. Eur Geriatr Med. 2020;11(5):813\u201320.","journal-title":"EUR GERIATR MED"},{"issue":"12","key":"5960_CR17","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.jacc.2020.07.045","volume":"76","author":"AJ Camm","year":"2020","unstructured":"Camm AJ, Cools F, Virdone S, Bassand JP, Fitzmaurice DA, Arthur FK, Goldhaber SZ, Goto S, Haas S, Mantovani LG, et al. Mortality in patients with atrial fibrillation receiving nonrecommended doses of direct oral anticoagulants. J AM Coll Cardiol. 2020;76(12):1425\u201336.","journal-title":"J AM COLL CARDIOL"},{"issue":"12","key":"5960_CR18","doi-asserted-by":"publisher","first-page":"e10062","DOI":"10.1161\/CIRCOUTCOMES.123.010062","volume":"16","author":"A Sandhu","year":"2023","unstructured":"Sandhu A, Kaltenbach LA, Chiswell K, Shimoga V, Ashur C, Pribish A, Fonarow GC, Piccini JS, Ho PM, Varosy PD, et al. Off-Label dosing of direct oral anticoagulants among inpatients with atrial fibrillation in the united States. Circ Cardiovasc Qual Outcomes. 2023;16(12):e10062.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"5960_CR19","doi-asserted-by":"crossref","unstructured":"Wang KL, Lip GY, Lin SJ, Chiang CE. Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis. Stroke. 2015;46(9):2555\u20132561.","DOI":"10.1161\/STROKEAHA.115.009947"},{"issue":"18","key":"5960_CR20","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1056\/NEJMoa2012883","volume":"383","author":"K Okumura","year":"2020","unstructured":"Okumura K, Akao M, Yoshida T, Kawata M, Okazaki O, Akashi S, Eshima K, Tanizawa K, Fukuzawa M, Hayashi T, et al. Low-Dose Edoxaban in very elderly patients with atrial fibrillation. New Engl J Med. 2020;383(18):1735\u201345.","journal-title":"NEW ENGL J MED"},{"key":"5960_CR21","doi-asserted-by":"crossref","unstructured":"Steinberg BA, Shrader P, Pieper K, Thomas L, Allen LA, Ansell J, Chan PS, Ezekowitz MD, Fonarow GC, Freeman JV et al. Frequency and outcomes of reduced dose Non-Vitamin K antagonist anticoagulants: results from ORBIT-AF II (The outcomes registry for better informed treatment of atrial fibrillation II). J AM Heart Assoc. 2018, 7(4).","DOI":"10.1161\/JAHA.117.007633"},{"issue":"12","key":"5960_CR22","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1016\/j.hrthm.2020.07.022","volume":"17","author":"YH Chan","year":"2020","unstructured":"Chan YH, Chao TF, Chen SW, Lee HF, Yeh YH, Huang YC, Chang SH, Kuo CT, Lip G, Chen SA. Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation. Heart Rhythm. 2020;17(12):2102\u201310.","journal-title":"HEART RHYTHM"},{"issue":"6","key":"5960_CR23","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.amjmed.2020.12.022","volume":"134","author":"H Ashraf","year":"2021","unstructured":"Ashraf H, Agasthi P, Shanbhag A, Mehta RA, Rattanawong P, Allam M, Pujari SH, Mookadam F, Freeman WK, Srivathsan K, et al. Long-Term clinical outcomes of underdosed direct oral anticoagulants in patients with atrial fibrillation and atrial flutter. AM J Med. 2021;134(6):788\u201396.","journal-title":"AM J MED"},{"issue":"6","key":"5960_CR24","doi-asserted-by":"publisher","first-page":"e24402","DOI":"10.1161\/JAHA.121.024402","volume":"11","author":"NE Vinding","year":"2022","unstructured":"Vinding NE, Butt JH, Olesen JB, Xian Y, Kristensen SL, Rorth R, Bonde AN, Gundlund A, Yafasova A, Weeke PE, et al. Association between inappropriately dosed anticoagulation therapy with stroke severity and outcomes in patients with atrial fibrillation. J AM Heart Assoc. 2022;11(6):e24402.","journal-title":"J AM HEART ASSOC"},{"issue":"21","key":"5960_CR25","doi-asserted-by":"publisher","first-page":"e29865","DOI":"10.1161\/JAHA.122.029865","volume":"12","author":"KN Hayes","year":"2023","unstructured":"Hayes KN, Zhang T, Kim DH, Daiello LA, Lee Y, Kiel DP, Berry SD, Zullo AR. Benefits and harms of standard versus Reduced-Dose direct oral anticoagulant therapy for older adults with multiple morbidities and atrial fibrillation. J AM Heart Assoc. 2023;12(21):e29865.","journal-title":"J AM HEART ASSOC"},{"issue":"9","key":"5960_CR26","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamacardio.2024.1793","volume":"9","author":"A Zimerman","year":"2024","unstructured":"Zimerman A, Braunwald E, Steffel J, Van Mieghem NM, Palazzolo MG, Murphy SA, Chen C, Unverdorben M, Ruff CT, Antman EM, et al. Dose reduction of Edoxaban in patients 80 years and older with atrial fibrillation: post hoc analysis of the ENGAGE AF-TIMI 48 randomized clinical trial. JAMA Cardiol. 2024;9(9):817\u201325.","journal-title":"JAMA CARDIOL"},{"issue":"8","key":"5960_CR27","first-page":"681","volume":"9","author":"YH Chan","year":"2023","unstructured":"Chan YH, Chao TF, Chen SW, Lee HF, Li PR, Yeh YH, Kuo CT, See LC, Lip G. Clinical outcomes in elderly atrial fibrillation patients at increased bleeding risk treated with very low dose vs. regular-dose non-vitamin K antagonist oral anticoagulants: a nationwide cohort study. Eur Heart J-Card Pha. 2023;9(8):681\u201391.","journal-title":"EUR HEART J-CARD PHA"},{"issue":"7","key":"5960_CR28","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1111\/jgs.18894","volume":"72","author":"MJ de Jong","year":"2024","unstructured":"de Jong MJ, Saadan H, Hellenbrand D, Ten CH, Spaetgens B, Bruggemann R, van Kuijk S, Winckers K, Henskens Y, Magdelijns F. The DOAC-FRAIL study, evaluation of direct oral anticoagulant-levels in acutely admitted frail older patients: an exploratory study. J AM Geriatr Soc. 2024;72(7):2249\u201353.","journal-title":"J AM GERIATR SOC"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-05960-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-025-05960-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-05960-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T07:39:31Z","timestamp":1745912371000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-025-05960-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5960"],"URL":"https:\/\/doi.org\/10.1186\/s12877-025-05960-3","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"15 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was adhered to the Declaration of Helsinki. This study was approved by the Ethics Committee Board of Beijing Hospital (approval no. 2023BYJYYEC-279-01). The need for consent to participate was waived by the Institutional Review Board of the Beijing Hospital as the study was retrospective, and all data were anonymized before analysis..","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"ChiCTR2300076161; registration date: 09\/26\/2023.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial registration"}}],"article-number":"292"}}